Amphastar Pharmaceuticals to Present at Jefferies Global Healthcare Conference

China Automotive Systems reported a 17.7% YoY increase in net sales to $193.2 million in Q3 2025, driven by a 77.3% rise in North American sales and a 30.5% increase in Brazilian sales. Gross profit rose 26.6% YoY to $33.4 million, with income from operations increasing 25.3% YoY to $13.9 million. Net income attributable to common shareholders jumped 75.6% to $9.7 million, and diluted EPS increased 77.8% to $0.32. The company raised its full-year guidance and had cash, cash equivalents, and short-term investments of $167.3 million as of September 30, 2025.